First US Lawsuit Filed Against AstraZeneca by Vaccine Trial Participant

Utah woman claims severe neurological condition from AstraZeneca COVID-19 vaccine trial, alleges breach of contract over medical expenses

Brianne Dressen, a former teacher, developed post-vaccine neuropathy after participating in the trial.
Dressen's lawsuit accuses AstraZeneca of failing to cover her extensive medical bills as promised.
The AstraZeneca vaccine, never approved in the US, is linked to rare neurological conditions in some cases.
More than 50 individuals have filed a similar class action lawsuit against AstraZeneca in the UK.
AstraZeneca acknowledges rare side effects but maintains the vaccine's overall safety profile.